← SynDRA
ERIBULIN
SynDRA canonical compound SYN0026381 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Mechanism of action | microtubule inhibitor |
|---|
| Indication | breast cancer |
|---|
| Disease area | oncology |
|---|
All known targets
- TUBB
- TUBB1
- TUBB2A
- TUBB2B
- TUBB3
- TUBB4A
- TUBB4B
- TUBB6
- TUBB8
Mechanisms of action (all sources)
- microtubule inhibitor
- TUBB INHIBITOR
- TUBB1 INHIBITOR
- TUBB2A INHIBITOR
- TUBB2B INHIBITOR
- TUBB3 INHIBITOR
- TUBB4A INHIBITOR
- TUBB4B INHIBITOR
- TUBB6 INHIBITOR
- TUBB8 INHIBITOR
Drug classes
ATC classes
- L01X · OTHER ANTINEOPLASTIC AGENTS
Cross-references
Synonyms
- eribulin mesylate
- halaven
- E7389
- eribulin mesilate
- Eribuline
- Eribulina
- B-1939
- E-7389 FREE BASE
- ER-086526
- B 1939
- LR24G6354G
- E-7389 free base
- eribuline
- CHEBI:63587
- nsc-707389
- eribulinum
- RefChem:56930
- L01XX41
- DTXCID701436148
- ER-86526
- ER086526
- Eribulin [INN]
- Eribulin free
- UNII-LR24G6354G
- ERIBULIN [MI]
- ERIBULIN [VANDF]
- ERIBULIN [MART.]
- ERIBULIN [WHO-DD]
- e7389-lf
- GTPL6813
- orb1707961
- SCHEMBL15783821
- EX-A4873D
- UFNVPOGXISZXJD-JBQZKEIOSA-N
- C40H59NO11
- GLXC-10730
- MFCD23160037
- AKOS040740784
Look up ERIBULIN in the interactive SynDRA portal →